{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T05:17:03Z","timestamp":1755839823348,"version":"3.41.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>This article reports a case of rare pulmonary metastases arising from an ovarian granulosa cell tumor using <jats:sup>18<\/jats:sup>F-NOTA-FAPI-04 PET\/CT. We discussed a patient who was diagnosed with ovarian granulosa cell tumor (stage IA) after surgery 15 years ago and developed pulmonary metastases. The metastatic lesions with solid and (or) cystic components displayed variable (none to mild) fluorodeoxyglucose (FDG) avidity and significantly higher uptake of FAPI. This case highlighted the utility of <jats:sup>18<\/jats:sup>F-NOTA-FAPI-04 PET\/CT, suggesting that it may serve as a promising novel tool for the diagnosis and staging of ovarian granulosa cell tumors.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005801","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T18:00:45Z","timestamp":1741024845000},"page":"e501-e502","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Pulmonary Metastases From Early-stage Granulosa Cell Tumor 15 Years Later on 18F-NOTA-FAPI-04 and 18F-FDG PET\/CT"],"prefix":"10.1097","volume":"50","author":[{"given":"Yan","family":"Cui","sequence":"first","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education\/Beijing)"},{"name":"NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education\/Beijing)"},{"name":"NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangping","family":"Guan","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education\/Beijing)"},{"name":"NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education\/Beijing)"},{"name":"NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"issue":"suppl 2","key":"R1-20250630","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0893-3952(22)04460-X","article-title":"Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems","volume":"18","author":"Young","year":"2005","journal-title":"Mod Pathol"},{"key":"R2-20250630","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2017.05.020","article-title":"Ovarian granulosa cell tumor: a National Cancer Database study","volume":"146","author":"Seagle","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R3-20250630","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tjog.2021.10.002","article-title":"Early-stage granulosa cell tumor with pelvic recurrence and lung metastasis 16 years later: a case report and review of the literature","volume":"61","author":"Yang","year":"2022","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R4-20250630","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1097\/RLU.0b013e31825b2583","article-title":"Revisiting the clinical value of 18F-FDG PET\/CT in detection of recurrent epithelial ovarian carcinomas: correlation with histology, serum CA-125 assay, and conventional radiological modalities","volume":"37","author":"Antunovic","year":"2012","journal-title":"Clin Nucl Med"},{"key":"R5-20250630","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/RLU.0b013e318292aa65","article-title":"Granulosa cell tumor of the ovary with high FDG uptake","volume":"38","author":"Caoduro","year":"2013","journal-title":"Clin Nucl Med"},{"key":"R6-20250630","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/RLU.0b013e3181b539e4","article-title":"Variable F-18 fluorodeoxyglucose avidity of metastatic recurrent adult granulosa cell tumor","volume":"34","author":"Huang","year":"2009","journal-title":"Clin Nucl Med"},{"key":"R7-20250630","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00595-012-0198-5","article-title":"Lung metastasis from an ovarian granulosa cell tumor 36 years after the initial diagnosis: report of a case","volume":"43","author":"Kimura","year":"2012","journal-title":"Surg Today"},{"key":"R8-20250630","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s00261-019-02172-3","article-title":"Multimodality imaging and genomics of granulosa cell tumors","volume":"45","author":"Elsherif","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"R9-20250630","doi-asserted-by":"crossref","first-page":"665","DOI":"10.18632\/oncotarget.27925","article-title":"[(18)F]FDG and [(18)F]FES positron emission tomography for disease monitoring and assessment of anti-hormonal treatment eligibility in granulosa cell tumors of the ovary","volume":"12","author":"Roze","year":"2021","journal-title":"Oncotarget"},{"key":"R10-20250630","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1097\/RLU.0000000000004530","article-title":"68 GA-FAPI-04 PET\/CT Versus 18 F-FDG PET\/CT in imaging of malignant mixed germ cell testicular tumor","volume":"48","author":"Kaplan","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R11-20250630","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/RLU.0000000000005453","article-title":"Superior identification of metastatic lesions by 68 Ga-FAPI-46 PET\/CT than 18 F-FDG PET\/CT in hepatic solitary fibrous tumor","volume":"49","author":"Fu","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R12-20250630","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/RLU.0000000000005191","article-title":"Occult SMARCA4-deficient undifferentiated carcinoma unmasked by 68 Ga-FAPI-46 PET\/CT","volume":"49","author":"Xu","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R13-20250630","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1097\/RLU.0000000000004523","article-title":"68Ga-FAPI versus 18F-FDG PET\/CT in evaluating newly diagnosed breast cancer patients: a head-to-head comparative study","volume":"48","author":"Zheng","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R14-20250630","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/RLU.0000000000004833","article-title":"Head-to-head comparison of 18 F-FDG and 68 Ga-FAPI-04 PET\/CT for radiological evaluation of cervical cancer","volume":"48","author":"Shu","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R15-20250630","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1097\/RLU.0000000000005148","article-title":"Intense 18 F-FAPI uptake in small recurrent lesions of combined hepatocellular-cholangiocarcinoma negative on 18 F-FDG PET\/CT","volume":"49","author":"Liang","year":"2024","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T16:01:21Z","timestamp":1751299281000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005801","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"type":"print","value":"0363-9762"},{"type":"electronic","value":"1536-0229"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"2024-10-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}